EV/EBITDA
-0.19
+0.02+9.52%
49 min ago
Summary
- As of February 7, 2025, RSLS EV/EBITDA is -0.19, with a rise of +0.02 (+9.52%) during the most recent trading day.
- Over the past year, RSLS EV/EBITDA has dropped by -0.16 (-533.33%).
- RSLS EV/EBITDA is now -120.65% below its all-time high of 0.92.
Performance
RSLS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RSLS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +9.5% | -10.7% | -8.0% |
| 1 m1 month | +45.7% | -46.9% | -39.1% |
| 3 m3 months | +53.7% | -54.1% | -46.8% |
| 6 m6 months | +60.4% | -66.6% | -72.6% |
| ytdytd | +38.7% | -39.3% | -32.1% |
| 1 y1 year | -533.3% | +200.8% | -75.3% |
| 5 y5 years | +99.3% | -99.9% | -99.9% |
RSLS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -0.38 | +50.0% | |
| 3 m | 3-month | -0.19 | at high | -0.46 | +58.7% |
| 6 m | 6-month | -0.19 | at high | -0.50 | +62.0% |
| 1 y | 1-year | 0.04 | -575.0% | -0.66 | +71.2% |
| 3 y | 3-year | 0.21 | -190.5% | -0.66 | +71.2% |
| 5 y | 5-year | 0.21 | -190.5% | -8184 | +100.0% |
| alltime | all time | 0.92 | -120.7% | -8184 | +100.0% |
ReShape Lifesciences EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.19(-38.7%) |
| 2024 | -0.31(+158.3%) |
| 2023 | -0.12(-1300.0%) |
| 2022 | 0.01(-110.0%) |
| 2021 | -0.10(-100.0%) |
| Date | Value |
|---|---|
| 2020 | -1483.09(+4917.2%) |
| 2019 | -29.56(-74.2%) |
| 2018 | -114.55(>+9900.0%) |
| 2017 | -0.28(-264.7%) |
| 2016 | 0.17 |
FAQ
- What is ReShape Lifesciences EV/EBITDA?
- What is the all time high EV/EBITDA for ReShape Lifesciences?
- What is RSLS EV/EBITDA year-to-date change?
- What is ReShape Lifesciences EV/EBITDA year-on-year change?
What is ReShape Lifesciences EV/EBITDA?
The current EV/EBITDA of RSLS is -0.19
What is the all time high EV/EBITDA for ReShape Lifesciences?
ReShape Lifesciences all-time high EV/EBITDA is 0.92
What is RSLS EV/EBITDA year-to-date change?
ReShape Lifesciences EV/EBITDA has changed by +0.12 (+38.71%) since the beginning of the year
What is ReShape Lifesciences EV/EBITDA year-on-year change?
Over the past year, RSLS EV/EBITDA has changed by -0.16 (-533.33%)